Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

Surgeon General Calls Youth Vaping a Public Health Threat

By Lauran Neergard, AP Medical Writer | December 8, 2016

 The U.S. surgeon general is calling e-cigarettes an emerging public health threat to the nation’s youth.

In a report being released Thursday, Surgeon General Vivek Murthy acknowledged a need for more research into the health effects of “vaping,” but said e-cigarettes aren’t harmless and too many teens are using them.

“My concern is e-cigarettes have the potential to create a whole new generation of kids who are addicted to nicotine,” Murthy told The Associated Press. “If that leads to the use of other tobacco-related products, then we are going to be moving backward instead of forward.”

Battery-powered e-cigarettes turn liquid nicotine into an inhalable vapor without the harmful tar generated by regular cigarettes. Vaping was first pushed as safer for current smokers. There’s no scientific consensus on the risks or advantages of vaping, including how it affects the likelihood of someone either picking up regular tobacco products or kicking the habit.

Federal figures show that last year, 16 percent of high school students reported at least some use of e-cigarettes – even some who say they’ve never smoked a conventional cigarette. While not all contain nicotine, Murthy’s report says e-cigarettes are the most commonly used tobacco-related product among youth.

Nicotine is bad for a developing brain no matter how it’s exposed, Murthy said.

“Your kids are not an experiment,” he says in a public service announcement being released with the report.

It’s already illegal to sell e-cigarettes to minors. Earlier this year, the Food and Drug Administration issued new rules that, for the first time, will require makers of nicotine-emitting devices to begin submitting their ingredients for regulators to review. The vaping industry argues the regulations will wipe out small companies in favor of more harmful products, and likely will lobby the incoming Trump administration to undo the rules.

Murthy’s report calls on parents and health workers to make concerns about e-cigarettes clear to young people. He said local officials should take action, too, such as including e-cigarettes in indoor smoke-free policies.


Filed Under: Drug Discovery

 

Related Articles Read More >

Lokavant’s Spectrum v15 uses AI to cut trial-feasibility modeling from weeks to minutes
Prime time for peptide-based drug discovery 
Why smaller, simpler molecular glues are gaining attention in drug discovery
Glass vial, pipette and woman scientist in laboratory for medical study, research or experiment. Test tube, dropper and professional female person with chemical liquid for pharmaceutical innovation
Unlocking ‘bench-to-bedside’ discoveries requires better data sharing and collaboration
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE